NOVEL PHARMA
Novel Pharma is distributes pharmaceutical products. It provides a range of drugs and perfumes. Novel Pharma conducts business in Spain.
NOVEL PHARMA
Industry:
Medical Pharmaceutical
Address:
Alcalá De Henares, Madrid, Spain
Country:
Spain
Status:
Active
Contact:
+34 918 83 69 59
Similar Organizations
Akacia Healthcare
Akacia Healthcare is distributes pharmaceutical products.
Ashbourne Pharmaceuticals
Ashbourne Pharmaceuticals distributes pharmaceutical products in the United Kingdom.
Cross Pharma AB
Cross Pharma is a distributor of pharmaceutical products.
Duopharm
Duopharm S.A distributes pharmaceutical products.
Juventas
Juventas distributes pharmaceutical products.
Schwarz Pharma AG
Schwarz Pharma develops pharmaceutical products.
More informations about "Novel Pharma"
NOVEL PHARMA
Pioneering Rare Disease Therapeutics. LEARN MORE. ⓒ 2022 Novel Pharma Inc.See details»
Company history – Novelpharm
Novelpharm is a subsidiary of Omnimedica AG, a spin-off company of ETH Zurich. Omnimedica AG was founded in 2001 by Dr. Hans E. Holzgang. As the scion of a well-known pharmacy …See details»
Novel Pharma Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Novel Pharma Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news, Disease Domain:Endocrinology and Metabolic Disease, Nervous System …See details»
A Brief History of the Company - novellpharm.com
After a worldwide merger between pharmaceutical giant Glaxo International and Burroughs Wellcome in 1996, a group of foreign and local investors acquired ex-PT.Burroughs Wellcome manufacturing plant in Indonesia and established a …See details»
Novel Pharma - Products, Competitors, Financials, Employees ...
Novel Pharma is a company focused on pioneering therapeutics for rare diseases within the pharmaceutical industry. The company's main offerings include the development of drugs …See details»
Regulatory Review of Novel Therapeutics — …
Jun 14, 2012 There were 510 applications for novel therapeutic agents approved from 2001 through 2010 — 225 by the FDA, 186 by the EMA, and 99 by Health Canada; among the applications, there were 289 unique ...See details»
NP-1031 - Drug Targets, Indications, Patents - Synapse
NP-1031, Initially developed by Novel Pharma Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases,Congenital Disorders,Endocrinology …See details»
Novel Pharma - Crunchbase Company Profile & Funding
Novel Pharma conducts business in Spain. Lists Featuring This Company. Edit Lists Featuring This Company Section. Europe, Middle East, and Africa (EMEA) Pharmaceutical Acquired …See details»
Novel drug targets in 2023 - Nature
Apr 2, 2024 Five of the nine drugs with novel targets are small molecules. These include one G-protein-coupled receptor antagonist and four enzyme inhibitors, which have seven novel …See details»
FDA Grants Fast Track Designation to GCBP and Novel Pharma's …
Jun 10, 2024 FDA's Fast Track designation speeds up the development of new biologic drugs for rare diseases; YONGIN, South Korea, June 10, 2024 /PRNewswire/ -- GC Biopharma …See details»
GondolaBio and n-Lorem Foundation Partner to Advance Novel …
Dec 17, 2024 PALO ALTO and SAN DIEGO, Calif., Dec. 17, 2024, (BUSINESS WIRE) n-Lorem, a nonprofit foundation, and GondolaBio, a clinical-stage biotechnology company founded in …See details»
Our Vision & Mission
Besides developing its own products, Novell is actively searching for new products by partnering with other multinational companies to market their novel products which are needed by …See details»
Innovations in Pharmacy: Describing Novel Drug ... - Pharmacist …
Jan 10, 2021 Novel drugs are typically created to help treat complex and/or medical conditions. For example, some of the more recent novel drug approvals in 2020 were approved to treat …See details»
Possible New Era in Pain Management: FDA Approves Novel Non …
Apr 15, 2025 For pharmaceutical companies, healthcare providers, and policymakers, the potential impact of suzetrigine could be significant. Vertex Pharmaceuticals, the maker of the …See details»
Novel Drug Approvals at FDA | FDA - U.S. Food and Drug …
When it comes to innovation in the development of new drugs and therapeutic biological products, FDA’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry …See details»
Pharmaceutical CDMO Market Size, Trends and Developments
Nov 7, 2024 The pharmaceutical CDMO market size surpassed USD 146.05 billion in 2023 is to reach USD 315.08 billion by 2034, registering at a CAGR of 7.24% from 2024 to 2034. ...See details»
A Novel Pharmaceutical Organization - ScienceDirect
Articles A Novel Pharmaceutical Organization* * Section on Education and Legislation, A. Ph. A., Dallas meeting, 1936.Oscar Loddy, References (1) Thompson, Ralph Estonia Rejects …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Pharma companies should identify the capabilities that are essential for their future portfolios and differentiate between areas where they must excel and those where industry …See details»
NEOVEL Pharma Pvt. Ltd. | For Better & Affordable Health Care
We are a fast-growing, innovative, and pioneering Pharmaceutical Organization which comprises specialized in the production of high-quality Health care & Pharmaceutical products. Neovel …See details»
Overview of the Market for Novel Medicines in the WHO European …
The Oslo Medicines Initiative (OMI) is a platform through which stakeholders can collaborate to develop ways of achieving better, more affordable access to novel, high-priced medicines. To …See details»